Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern
- PMID: 29261653
- PMCID: PMC5737881
- DOI: 10.1371/journal.pbio.2002855
Key scientific issues in developing drinking water guidelines for perfluoroalkyl acids: Contaminants of emerging concern
Abstract
Perfluoroalkyl acids (PFAAs), a group of synthetic organic chemicals with industrial and commercial uses, are of current concern because of increasing awareness of their presence in drinking water and their potential to cause adverse health effects. PFAAs are distinctive among persistent, bioaccumulative, and toxic (PBT) contaminants because they are water soluble and do not break down in the environment. This commentary discusses scientific and risk assessment issues that impact the development of drinking water guidelines for PFAAs, including choice of toxicological endpoints, uncertainty factors, and exposure assumptions used as their basis. In experimental animals, PFAAs cause toxicity to the liver, the immune, endocrine, and male reproductive systems, and the developing fetus and neonate. Low-dose effects include persistent delays in mammary gland development (perfluorooctanoic acid; PFOA) and suppression of immune response (perfluorooctane sulfonate; PFOS). In humans, even general population level exposures to some PFAAs are associated with health effects such as increased serum lipids and liver enzymes, decreased vaccine response, and decreased birth weight. Ongoing exposures to even relatively low drinking water concentrations of long-chain PFAAs substantially increase human body burdens, which remain elevated for many years after exposure ends. Notably, infants are a sensitive subpopulation for PFAA's developmental effects and receive higher exposures than adults from the same drinking water source. This information, as well as emerging data from future studies, should be considered in the development of health-protective and scientifically sound guidelines for PFAAs in drinking water.
Conflict of interest statement
All three authors are members of the New Jersey Drinking Water Quality Institute (DWQI), an advisory body to the New Jersey Department of Environmental Protection. The DWQI recommends drinking water standards for contaminants of concern in NJ based on relevant scientific information. It recently completed evaluations of two PFAAs—PFOA and PFNA. The views expressed herein do not necessarily reflect those of the New Jersey Department of Environmental Protection or the New Jersey Department of Health.
Figures


References
-
- Buck RC, Franklin J, Berger U, Conder JM, Cousins IT, de Voogt P, et al. Perfluoroalkyl and polyfluoroalkyl substances in the environment: terminology, classification, and origins. Integrated environmental assessment and management. 2011;7(4):513–41. Epub 2011/07/28. doi: 10.1002/ieam.258 ; PubMed Central PMCID: PMCPMC3214619. - DOI - PMC - PubMed
-
- Fromme H, Wockner M, Roscher E, Volkel W. ADONA and perfluoroalkylated substances in plasma samples of German blood donors living in South Germany. International journal of hygiene and environmental health. 2017;220(2 Pt B):455–60. Epub 2017/01/12. doi: 10.1016/j.ijheh.2016.12.014 . - DOI - PubMed
-
- Post GB, Louis JB, Lippincott RL, Procopio NA. Occurrence of perfluorinated compounds in raw water from New Jersey public drinking water systems. Environmental science & technology. 2013;47(23):13266–75. Epub 2013/11/06. doi: 10.1021/es402884x . - DOI - PubMed
-
- USEPA (2017). Occurence Data for the Unregulated Contaminant Monitoring Rule—UCMR3 (2013–2015) occurence data. Updated January 2017. Available from: https://www.epa.gov/dwucmr/occurrence-data-unregulated-contaminant-monit.... Accessed April 10, 2017
-
- Lindstrom AB, Strynar MJ, Libelo EL. Polyfluorinated compounds: past, present, and future. Environmental science & technology. 2011;45(19):7954–61. Epub 2011/08/27. doi: 10.1021/es2011622 . - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical